Prosight Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Prosight Management’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-59,168	Closed	-$924K	–	48
2019 Q3	$924K	Sell	59,168 -7,872	-12%	-$151K	0.51%	33
2019 Q2	$1.5M	Buy	67,040 +5,598	+9%	+$271K	0.76%	29
2019 Q1	$4.2M	Sell	61,442 -2,407	-4%	-$154K	1.84%	21
2018 Q4	$3.37M	Sell	63,849 -4,153	-6%	-$265K	1.74%	22
2018 Q3	$4.62M	Buy	68,002 +22,838	+51%	+$2.07M	2.58%	16
2018 Q2	$5.35M	Sell	45,164 -18,299	-29%	-$1.84M	3.92%	13
2018 Q1	$5.26M	Buy	+63,463	New	+$7.2M	3.3%	10

Other funds holding SRRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

New Leaf Venture Partners New York $43M AUM 33.95% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Hikari Power Tokyo, Japan $439M AUM 11.38% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Abingworth London, United Kingdom $304M AUM 95.02% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $9.8B AUM 2.94% 1-Year Est. Return

Prosight Management's SRRA Position: Q4 2019 in Review

Prosight Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2019, closing a stake of 59,168 shares — an estimated $924K sold.

Prosight Management first reported a position in SRRA in Q1 2018 and held it in 7 quarters. The position peaked at $5.35M in Q2 2018. 29 funds tracked by Wall St. Rank hold SRRA as of Q4 2019.

Prosight Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Prosight Management sold 59,168 Sierra Oncology, Inc. Common Stock shares in Q4 2019, an estimated $924K.
Prosight Management first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Prosight Management's Sierra Oncology, Inc. Common Stock position peaked at $5.35M in Q2 2018.
29 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2019.

Based on Prosight Management's 13F filing for Q4 2019, filed 14 Feb 2020.